{"id":"NCT02587221","sponsor":"Seqirus","briefTitle":"Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age","officialTitle":"A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-09-30","primaryCompletion":"2018-07-23","completion":"2018-07-23","firstPosted":"2015-10-27","resultsPosted":"2020-06-09","lastUpdate":"2020-06-17"},"enrollment":6790,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza"],"interventions":[{"type":"BIOLOGICAL","name":"MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)","otherNames":[]},{"type":"BIOLOGICAL","name":"Non-Influenza Comparator (Boostrix)","otherNames":[]}],"arms":[{"label":"aQIV","type":"EXPERIMENTAL"},{"label":"Non-influenza Comparator Vaccine","type":"PLACEBO_COMPARATOR"}],"summary":"A Phase III, Randomized, Observer-Blind, Controlled, Multicenter Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age.","primaryOutcome":{"measure":"Absolute Vaccine Efficacy (VE) of aQIV Versus Non-influenza Comparator Based on RT-PCR-confirmed Influenza Due to Any Strain Using Protocol Defined ILI Definition.","timeFrame":"Day 21 to Day 180 after vaccination or end of influenza season, whichever is longer","effectByArm":[{"arm":"aQIV","deltaMin":122,"sd":null},{"arm":"Non-influenza Comparator Vaccine","deltaMin":151,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":89,"countries":["Bulgaria","Colombia","Czechia","Estonia","Latvia","Lithuania","Malaysia","Philippines","Poland","Romania","Thailand","Turkey (Türkiye)"]},"refs":{"pmids":["33577767"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":238,"n":3380},"commonTop":["Pain","Erythema","Fatigue","Headache","Induration"]}}